购物车
- 全部删除
- 您的购物车当前为空
(R)-Atuveciclib是Atuveciclib的异构体。Atuveciclib (BAY 1143572)是强效和高选择性的PTEFb/CDK9抑制剂,对CDK9/CycT1的IC50值为13 nm,对CDK2的选择性比值为100,具有生物利用度高和可口服的优点。
(R)-Atuveciclib是Atuveciclib的异构体。Atuveciclib (BAY 1143572)是强效和高选择性的PTEFb/CDK9抑制剂,对CDK9/CycT1的IC50值为13 nm,对CDK2的选择性比值为100,具有生物利用度高和可口服的优点。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | ¥ 15,298 | 5日内发货 |
产品描述 | (R)-Atuveciclib is an isomer of Atuveciclib. Atuveciclib (BAY 1143572) is a potent and highly selective PTEFb/CDK9 inhibitor with an IC50 value of 13 nm for CDK9/CycT1 and a selectivity ratio of 100 for CDK2, with highly bioavailable and orally available advantages. |
靶点活性 | CDK5-p35:1600 nM, CDK9-CyclinT1:13 nM, CDK9-CyclinT1:6 nM, CDK1-CyclinB:1100 nM, CDK2-CyclinE:1000 nM, CDK3-CyclinE:890 nM |
别名 | BAY-1143572 |
分子量 | 387.43 |
分子式 | C18H18FN5O2S |
CAS No. | 2923012-24-0 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 128.5 mg/mL (331.67 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容